Yes, I will not ever invest in OTC again. That doesn't mean that ONCS will not be a success. But I think a reverse split and more dilution is in the cards before significant price appreciation here. Check back a year from now. The opportunity cost is too great to be out if other stocks that are primed for big moves in 2015. Notably SYN. IDRA too. Check out the seeking alpha article on SYN out a few weeks ago to start your DD. I think you will really like what you find. Good luck ONCSers!
Someone or some entity has definitely been buying this week. Too many 15,000+ share buy trades with many over 25,000 to be average joes. A possible alternative is that the buyer or buyers is/are selling enough strategically to create what we see now in order to keep accumulating at favorable prices. Also looks like a couple traders taking profits today.
We will know soon.
SYN....a potential candidate for one of the best bios of 2015 if best case plays out.
Not advice, but I would set a buy order for SYN at the 10 day and "hope" it hits. Keep in mind that SYN is way undervalued at current Marketcap based on their pipeline and strong investor support (Randall J Kirk/Third Security LLC). They should have 3 multi billion drugs in phase 3 by early 2016.
Good choice and welcome. My personal PT for year end is: $12-$15. Assumes a lucrative partnership is struck in first half of this year sometime. I have great confidence in Riley and Kirk getting this done.
As opposed to you discouraging people from investing here and making $ without any facts. Can't believe you have the audacity to even post here anymore. Go find another hobby or job.
Glad you are here fighterpilot! I do most of my postings on Stocktwits nowadays, but you'll find some great contributors and posters on this yahoo message board. That number is only growing by the day it seems as SYN is attracting smart $ by the day it seems. Good luck!
Long and strong SYN
I don't know about you or anyone else here, but ya gotta love two people arguing about Golden crosses and Cup and Handles! $SYN,..undervalued and still under the radar.
Sentiment: Strong Buy
Hi Kg,...I feel really good about it. The only question with Trimesta for me is just how much more is it going to be worth to Big Pharma after Voskhul publishes/MRI results.
Still in the 30s here I see. Haven't been following this issue too closely lately, but hope this can get some traction soon for some long timers here (Flight and others). If anyone has any extra $, do some looking at SYN. They should have 3 multi billion drugs in phase 3 by Speing of 2016. There is a good Seeking Alpha article posted a few weeks ago that will go a long ways towards helping you with your #due diligence. Randall Kirk company too! All for $2.07.
50 day ma: 1.64
200 day ma: 1.66
Looking good for the Golden Cross next week? Maybe the timing will line up with P2a Syn-004 (C-Diff) commencement,..Tuesday PR would be my "guess." Fun to speculate! Really happy with the way $SYN is setting up fundamentally and technically. Accumulate on any dips and let er' ride for the big $$
Sentiment: Strong Buy
Iggy specializes in ignore as I understand it. :)
Not Tursta,..but I sold $ONCS and invested in $SYN. Like you, I won't go back to OTC. Not sure if you got my message directed to you here the other day regarding your question about SYN?
I like the sounds of "greedy" big pharmas wanting it all for themselves. Kirk will make sure the deal is very beneficial for shareholders here imo.
* 3 multi billion dollar drugs (including C-Diff prevention tablet) all for 2.13 as of the close on Friday